Documentos relacionados

1. Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the Diagnosis of aPL Nephropathy: You Can't Have One Without the Other.
2. The estimated prevalence of antiphospholipid antibodies and criteria-antiphospholipid syndrome in subjects with renal thrombotic microangiopathy.
3. Update on antiphospholipid syndrome.
4. Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS.
5. Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome.
6. Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome.
7. How I diagnose and treat antiphospholipid syndrome in pregnancy.
8. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms.
9. Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.
10. Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?